The effects of ganglioside treatment on changes in dopaminergic funciton following 6‐hydroxydopamine (6‐OHDA) or repeated exposure to haloperidol were studied in male Fischer‐344 rats.Rats were injected sc with 30 mg/kg of a mixed ganglioside preparation (GM) at the time of the surgery and for 13 days after receiving an intranigral injection of 6‐OHDA. GM treatment attenuated 6‐OHDA depletion of striatal dopameine (DA) and DOPAC. Another group of rats was implanted with chronic indwelling cannulas in the lateral cerebroventricles at the time of 6‐OHDA administration into the substantia nigra. Daily intraventricular injection of 25 or 50 μg GM attenuated depletions of striatal DA and DOPAC. A separate experiment sought to determine the effects of GMI on the development of receptor supersensitivity produced by repeated exposure to a dopamine receptor antagonist, rats were injected sc with 1 mg/kg haloperidol for 8 or for 16 days; some rats were coadministered 2 mg/kg GMI sc. Four days after the last dose, the rats were challenged with 1 mg/kg apomorphine, and activity was counted for 6 min. Treatment with GMI decreased the behavioral supersensitivity to apomorphine induced by repeated exposure to haloperido. Theses experiments suggest that treatment with GM can have a protective effect against 6‐OHDA‐induced depletion of dopamine if treatment with GM begins at the time of lesioning. These studies also support receptor binding data from other laboraories indicating that treatment with GM1 can affect up‐regulation of dopamine receptors.
Journal of Neuroscience Research – Wiley
Published: Jan 1, 1988
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera